Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
Published on: September 6, 2024
Phosphatonins: From Discovery to Therapeutics
Kittrawee Kritmetapak1, Rajiv Kumar2
1Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Fibroblast growth factor 23 (FGF23) plays a key role in phosphate homeostasis. The anti-FGF23 antibody burosumab effectively treats FGF23-related hypophosphatemic disorders like XLH and TIO in children and adults.
Area of Science:
- Endocrinology
- Nephrology
- Bone Metabolism
Background:
- Phosphate is vital for cellular functions and bone health.
- The gut-bone-parathyroid-kidney axis regulates phosphate homeostasis via hormones like FGF23.
- Dysregulation of FGF23 causes hypophosphatemic disorders.
Purpose of the Study:
- To review phosphate homeostasis and FGF23 pathophysiology.
- To discuss clinical implications of FGF23-related hypophosphatemic disorders.
- To focus on burosumab treatment for these conditions.
Main Methods:
- Focused literature search of PubMed.
Main Results:
- Excess FGF23 leads to hyperphosphaturia and hypophosphatemia by inhibiting phosphate cotransporters and vitamin D synthesis.
- FGF23-related disorders include XLH, ADHR, ARHR, fibrous dysplasia/McCune-Albright syndrome, and TIO.
- Burosumab, an anti-FGF23 antibody, shows a favorable safety profile and efficacy in healing rickets and osteomalacia in XLH and TIO patients.
Conclusions:
- Recent clinical trials are transforming the treatment of XLH and TIO.
- Burosumab demonstrates effectiveness and safety for pediatric and adult patients with XLH or TIO.
More Related Videos
10:17A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
Published on: April 29, 2022
08:21Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method
Published on: May 18, 2018
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
The Phosphorus Cycle
Drug Discovery: Overview